FMOD and breast cancer: As schematically illustrated in Figure 9F, our present results show that when the Wnt/β-catenin pathway is activated, β-catenin translocates into the nucleus where it forms a transcription complex with TCF4 and LEF1, which then promotes FMOD transcription and subsequent ERK activation leading to breast cancer cell migration and invasion.